Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors.Shin, Y., Chen, W., Habel, J., Duckett, D., Ling, Y.Y., Koenig, M., He, Y., Vojkovsky, T., LoGrasso, P., Kamenecka, T.M.
(2009) Bioorg Med Chem Lett 19: 3344-3347
- PubMed: 19433357
- DOI: https://doi.org/10.1016/j.bmcl.2009.03.086
- Primary Citation of Related Structures:
- PubMed Abstract:
A novel series of c-jun N-terminal kinase (JNK) inhibitors were designed and developed from a high-throughput-screening hit. Through the optimization of the piperazine amide 1, several potent compounds were discovered. The X-ray crystal structure of 4g showed a unique binding mode different from other well known JNK3 inhibitors.
Department of Molecular Therapeutics, and Translational Research Institute, The Scripps Research Institute, Scripps Florida, 130 Scripps Way #A2A, Jupiter, FL 33458, USA.